Poster
Predicted Metabolites from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice
October 23, 2021
Development and Validation of a Novel T Cell Modulating, Microbiome-Based Peptide for Combination with Immunotherapy
October 1, 2021
A Novel Microbiome‑Derived Peptide, SG‑3‑00802 Reverses Resistance to Anti‑Programmed Death Protein‑1 (PD‑1) Therapy
September 1, 2021
Metabolites Predicted from Multiple Microbiome Sequencing Datasets Modulate Autism Spectrum Phenotype in Mice
July 16, 2021
Novel intestinal microbiome-derived peptides modulates immune cell activity and the tumor microenvironment
November 11, 2019
Leveraging the Second Genome platform to develop microbiome-derived cancer immunotherapies
October 30, 2019